Culturally-adapted Mobile Health Intervention for Hypertension Care
AHOMKA
AHOMKA Qualitative Study For Adaptation of the Medtronic Empower Health Platform
1 other identifier
interventional
160
1 country
2
Brief Summary
A single-arm study to assess the ability of the AHOMKA platform for hypertension management to affect blood pressure change among urban and rural patients in Ghana.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Oct 2024
Shorter than P25 for not_applicable hypertension
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 31, 2024
CompletedFirst Submitted
Initial submission to the registry
May 14, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedJuly 18, 2025
July 1, 2025
9 months
May 14, 2025
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Blood Pressure levels from Baseline
Changes in blood pressure levels, measured in mmHg, will be assessed at the baseline and 6-month endline visit.
Baseline, 6 months
Study Arms (1)
Enhanced Usual Care Group
EXPERIMENTALParticipants with uncontrolled hypertension and the owner of a cell phone are selected. Participants will receive usual care as determined by their provider.
Interventions
A culturally-adapted mobile health platform will be used in the intervention to enable participants to record blood pressure and heart rate readings at home and store data in the mobile platform. Providers will have access to the store data using a provider-facing app.
Eligibility Criteria
You may qualify if:
- diagnosis of hypertension
You may not qualify if:
- Comorbidities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Universitylead
- University of Ghana Medical Schoolcollaborator
- Beth Israel Deaconess Medical Centercollaborator
- University of Health and Allied Sciencescollaborator
Study Sites (2)
National Cardiothoracic Center
Accra, Ghana, Ghana
Cardiothoracic Center - Outpatient Department
Ho, Ghana, Ghana
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valencia Koomson
Tufts University
- PRINCIPAL INVESTIGATOR
Mark Tettey, MD
University of Ghana
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2025
First Posted
May 22, 2025
Study Start
October 31, 2024
Primary Completion
July 31, 2025
Study Completion
September 30, 2025
Last Updated
July 18, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share